Assetmark, Inc Ionis Pharmaceuticals Inc Transaction History

Assetmark, Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	SELL	$42.03 - $53.55 $252 - $321	-6 Reduced 85.71%	1 $0
Q4 2023 Feb 09, 2024	BUY	$43.39 - $51.63 $303 - $361	7 New	7 $0
Q3 2022 Nov 01, 2022	BUY	$36.54 - $48.66 $9,135 - $12,165	250 New	250 $11,000
Q4 2019 Feb 11, 2020	SELL	$53.85 - $65.27 $1,346 - $1,631	-25 Closed	0 $0
Q1 2018 May 16, 2018	SELL	$44.08 - $55.05 $2,027 - $2,532	-46 Reduced 64.79%	25 $1,000
Q4 2017 Feb 13, 2018	BUY	$50.3 - $64.39 $3,319 - $4,249	66 Added 1320.0%	71 $4,000
Q3 2017 Nov 08, 2017	BUY	$45.56 - $59.57 $227 - $297	5	5 $0

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

Stay updated on Assetmark, Inc with notifications on news.